IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS. CRISMW 2025, 2 (5), 137-142.